» Articles » PMID: 36246919

Free Fatty Acid Receptors in the Endocrine Regulation of Glucose Metabolism: Insight from Gastrointestinal-pancreatic-adipose Interactions

Overview
Specialty Endocrinology
Date 2022 Oct 17
PMID 36246919
Authors
Affiliations
Soon will be listed here.
Abstract

Glucose metabolism is primarily controlled by pancreatic hormones, with the coordinated assistance of the hormones from gastrointestine and adipose tissue. Studies have unfolded a sophisticated hormonal gastrointestinal-pancreatic-adipose interaction network, which essentially maintains glucose homeostasis in response to the changes in substrates and nutrients. Free fatty acids (FFAs) are the important substrates that are involved in glucose metabolism. FFAs are able to activate the G-protein coupled membrane receptors including GPR40, GPR120, GPR41 and GPR43, which are specifically expressed in pancreatic islet cells, enteroendocrine cells as well as adipocytes. The activation of FFA receptors regulates the secretion of hormones from pancreas, gastrointestine and adipose tissue to influence glucose metabolism. This review presents the effects of the FFA receptors on glucose metabolism the hormonal gastrointestinal-pancreatic-adipose interactions and the underlying intracellular mechanisms. Furthermore, the development of therapeutic drugs targeting FFA receptors for the treatment of abnormal glucose metabolism such as type 2 diabetes mellitus is summarized.

Citing Articles

Fetal Hypoglycemia Induced by Placental -RNA Interference Alters Fetal Pancreas Development and Transcriptome at Mid-Gestation.

Kennedy V, Lynch C, Tanner A, Winger Q, Gad A, Rozance P Int J Mol Sci. 2024; 25(9).

PMID: 38731997 PMC: 11084495. DOI: 10.3390/ijms25094780.


Effects of nutrient metabolism on pancreatic β-cell mass and function: Recent findings.

Yasuda T, Harada N J Diabetes Investig. 2023; 14(11):1234-1236.

PMID: 37424266 PMC: 10583648. DOI: 10.1111/jdi.14052.


Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes.

Gusev E, Sarapultsev A Int J Mol Sci. 2023; 24(9).

PMID: 37175617 PMC: 10178362. DOI: 10.3390/ijms24097910.

References
1.
Stone V, Dhayal S, Brocklehurst K, Lenaghan C, Winzell M, Hammar M . GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans. Diabetologia. 2014; 57(6):1182-91. PMC: 4018485. DOI: 10.1007/s00125-014-3213-0. View

2.
Osinski C, Moret D, Clement K, Serradas P, Ribeiro A . Enteroendocrine System and Gut Barrier in Metabolic Disorders. Int J Mol Sci. 2022; 23(7). PMC: 8998765. DOI: 10.3390/ijms23073732. View

3.
Schnell S, Schaefer M, Schofl C . Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Mol Cell Endocrinol. 2006; 263(1-2):173-80. DOI: 10.1016/j.mce.2006.09.013. View

4.
Wang A, Li T, An P, Yan W, Zheng H, Wang B . Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway. PLoS One. 2017; 12(1):e0169469. PMC: 5266308. DOI: 10.1371/journal.pone.0169469. View

5.
Namour F, Galien R, Van Kaem T, Van der Aa A, Vanhoutte F, Beetens J . Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects. Br J Clin Pharmacol. 2016; 82(1):139-48. PMC: 4917808. DOI: 10.1111/bcp.12900. View